Cutaneous and Systemic Leishmaniasis Market Size, Share, Growth, and Regional Forecast, 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Cutaneous and Systemic Leishmaniasis Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Product Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. Key Deals and Mergers
   5. PESTLE Analysis
   6. Porter’s Five Force Analysis
4. Global Cutaneous and Systemic Leishmaniasis Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
   3. Global Cutaneous and Systemic Leishmaniasis Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
         1. Pentavalent Antimonials
         2. Antifungal Drugs
         3. Antimicrobial Drugs
         4. Others
      4. Market Attractiveness Analysis: By Drug Class
   4. Global Cutaneous and Systemic Leishmaniasis Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
         1. Oral
         2. Injectable
         3. Topical
      4. Market Attractiveness Analysis: Route of Administration
   5. Global Cutaneous and Systemic Leishmaniasis Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
         1. Hospital Pharmacies
         2. Retail Pharmacies
         3. Drug Stores
         4. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
5. Global Cutaneous and Systemic Leishmaniasis Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
   3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Cutaneous and Systemic Leishmaniasis Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Pentavalent Antimonials
      2. Antifungal Drugs
      3. Antimicrobial Drugs
      4. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Injectable
      3. Topical
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Drug Stores
      4. Online Pharmacies
   7. Market Attractiveness Analysis
7. Europe Cutaneous and Systemic Leishmaniasis Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Pentavalent Antimonials
      2. Antifungal Drugs
      3. Antimicrobial Drugs
      4. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Injectable
      3. Topical
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Drug Stores
      4. Online Pharmacies
   7. Market Attractiveness Analysis
8. East Asia Cutaneous and Systemic Leishmaniasis Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Pentavalent Antimonials
      2. Antifungal Drugs
      3. Antimicrobial Drugs
      4. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Injectable
      3. Topical
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Drug Stores
      4. Online Pharmacies
   7. Market Attractiveness Analysis
9. South Asia & Oceania Cutaneous and Systemic Leishmaniasis Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Pentavalent Antimonials
      2. Antifungal Drugs
      3. Antimicrobial Drugs
      4. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Oral
      2. Injectable
      3. Topical
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Drug Stores
      4. Online Pharmacies
   7. Market Attractiveness Analysis
10. Latin America Cutaneous and Systemic Leishmaniasis Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Drug Class
       3. By Route of Administration
       4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
       1. Pentavalent Antimonials
       2. Antifungal Drugs
       3. Antimicrobial Drugs
       4. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
       1. Oral
       2. Injectable
       3. Topical
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       1. Hospital Pharmacies
       2. Retail Pharmacies
       3. Drug Stores
       4. Online Pharmacies
    7. Market Attractiveness Analysis
11. Middle East & Africa Cutaneous and Systemic Leishmaniasis Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Drug Class
       3. By Route of Administration
       4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
       1. Pentavalent Antimonials
       2. Antifungal Drugs
       3. Antimicrobial Drugs
       4. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
       1. Oral
       2. Injectable
       3. Topical
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       1. Hospital Pharmacies
       2. Retail Pharmacies
       3. Drug Stores
       4. Online Pharmacies
    7. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Gilead Sciences, Inc.
          1. Overview
          2. Segments and Drug Classs
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Profounda Pharmaceuticals
       3. Knight Therapeutics Inc.
       4. Janssen Global Services, LLC
       5. Albert David Ltd.
       6. Jubilant Life Sciences Ltd.
       7. Novartis AG
       8. Endo Pharmaceuticals Inc
       9. Lifecare Innovations Pvt Ltd
       10. Bristol-Myers Squibb Company
       11. United Biotech Pvt. Ltd.
       12. Taj Pharmaceuticals
       13. Centurion Healthcare Pvt Ltd
       14. Others
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations